{
    "id": "606b718994d57fd87900006b",
    "question": "Has dupilumab been FDA approved for atopic dermatitis?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, I need to check the FDA approval status of dupilumab for atopic dermatitis. Dupilumab is a medication used to treat various autoimmune diseases, and it has been approved for several conditions. One of its indications is atopic dermatitis, also known as atopic eczema. Let me verify the FDA approval status of dupilumab for atopic dermatitis.\\n\\nDupilumab (Dupixent) is a human monoclonal antibody that targets the interleukin-4 receptor alpha subunit (IL-4R\\u00b1) and the interleukin-13 receptor alpha subunit (IL-13R\\u00b1). It is used to treat moderate-to-severe atopic dermatitis (AD) in adults and children 6 years and older, as well as in adults with moderate-to-severe asthma and eosinophilic asthma.\\n\\nBased on my knowledge, dupilumab has been approved by the FDA for the treatment of atopic dermatitis.\\n\\nTherefore, the answer is A. yes.\", \"answer_choice\": \"A\"}",
    "snippets": [],
    "scores": [],
    "execution_time": 15.953234910964966
}